Actimmune: Completed Phase II study enrollment

InterMune Pharmaceuticals Inc., Palo Alto, Calif.
Product: Actimmune
Business: Infectious diseases

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE